로그인
회원가입
Korean
Korean
English
Chinese
Japanese
Home
Introduction
Contact us
People
PI
Members
Research
Projects
Lab Facility
Publications
Papers
Books
Patents
Photo gallery
Photo gallery
Board
Projet update
Recruiting
Journal club
Home
People
Research
Publications
Photo gallery
Board
Home
Introduction
Contact us
People
PI
Members
Research
Projects
Lab Facility
Publications
Papers
Books
Patents
Photo gallery
Photo gallery
Board
Projet update
Recruiting
Journal club
MOON LAB SNS 바로가기
트위터
페이스북
네이버블로그
MOON LAB
홈페이지 바로가기
MOON LAB
Moon lab pursues development of novel therapeutics for breast, ovary, and prostate cancer
Journal club 글답변
이름
필수
비밀번호
필수
분류
선택하세요
Journal Club
Projet update
HTML
제목
필수
웹에디터 시작
> > > Title : Metformin reverses PARP inhibitors-induced Epithelial-mesenchymal transition and PD-L1 upregulation in the Triple-negative breast cancer > Ye Han, et al. Am J Cancer Res 2019;9(4): 800-815 > PARP inhibitors induce the EMT features and the upregulation of PD-L1 in the PARP senstive/resistant cell line. > But, Metformin or Topoisomerase 2 poisons (Doxorubicin, Epirubicin, Daunorubicin) treat about that EMT featured make reversal to MET. > And, Phosphorylation of Akt is important to Reversal of EMT to MET is explained by treat the Akt inhibitor, that reversal of PARPi-induced EMT and PD-L1 upregulation is blocked. > >
웹 에디터 끝
첨부파일
파일추가
파일삭제
자동등록방지
숫자음성듣기
새로고침
자동등록방지 숫자를 순서대로 입력하세요.
작성완료
취소
전화걸기
문자상담
PL
MEMBERS